Brian K. Kennedy

Brian K. Kennedy is the former President and CEO of the Buck Institute for Research on Aging in Novato, California. Having started in July, 2010, Kennedy was asked to resign in October 2016.[1][2] Kennedy's resignation raised serious questions about Buck Leadership.[3]

Brian K. Kennedy
Born1967 (age 52–53)
Louisville, Kentucky, United States
NationalityAmerican
Alma materNorthwestern University
Massachusetts Institute of Technology
Scientific career
InstitutionsBuck Institute for Research on Aging
University of Washington
Guangdong Medical College
Doctoral advisorLeonard P. Guarente

Kennedy has published over 80 manuscripts in prestigious journals including Cell, Nature, Science, Genes & Development, and PNAS. Potential public health benefits claimed in one study were questioned by the UK National Health Service in 2014.[4]

Kennedy has served on the NIH Cellular Mechanisms of Aging and Development study section since 2006, acting as Committee Chair since 2010. He has also served on the grant review committee for American Federation for Aging Research Grants since 2006. He has acted as an Associate Editor for the Journal of Gerontology: Biological Science since 2006 and Cell Cycle since 2010. Currently, he is co-Editor-in Chief of Aging Cell. Kennedy has served as a consultant for Biotech and Pharmaceutical companies[5][6] and is a co-Founder of the Nuvita Animal Health Corporation, a now defunct dog food company.[7] He is also Chairman of Mount Tam Biotechnologies,[8] which is traded as a penny stock.[9] In August 2016, Mount Tam Biotechnologies merged with Tabacalera Ysidron,[10] a defunct cigar company which had failed in its plan to distribute Nicaraguan cigars.[11]

References
  1. "Buck Institute changes CEOs as talks with Gladstone Institutes fizzle". Marinij.com. 2016-10-28. Retrieved 2017-06-17.
  2. "At Buck Institute, second top executive resigns". Marinij.com. Retrieved 2017-06-17.
  3. "Novato: Buck institute shakeup leaves lingering funding, leadership questions". Marinij.com. 2016-11-29. Retrieved 2017-06-17.
  4. "Ibuprofen unlikely to extend life - Health News - NHS Choices". Nhs.uk. 2014-12-19. Retrieved 2017-06-17.
  5. "Novato's Mount Tam Biotechnologies goes public via reverse merger with cigar maker". The North Bay Business Journal. 2016-06-20. Retrieved 2017-06-17.
  6. "Vision & Mission". Ehealthcardusa.com. 2016-11-25. Archived from the original on 2016-11-18. Retrieved 2017-06-17.
  7. "NUVITA ANIMAL HEALTH CORPORATION - California Company Directory". Cacompany.org. Retrieved 2017-06-17.
  8. "Mount tam Biotechnologies Homepage". Mounttambiotech.vom. Retrieved 2017-06-17.
  9. "MNTM Stock Price - Mount TAM Biotechnologies Inc. Stock Quote (U.S.: OTC)". MarketWatch. Retrieved 2017-06-17.
  10. "Tabacalera Ysidron, Inc.: Private Company Information". Bloomberg. 2015-08-13. Retrieved 2017-06-17.
  11. "Novato's Mount Tam Biotechnologies goes public via reverse merger with cigar maker". The North Bay Business Journal. 2016-06-20. Retrieved 2017-06-17.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.